Mass. biotech companies still raising venture capital

07/7/2008 | Boston Globe (tiered subscription model), The

Biotech companies in Massachusetts continue to gain investments amid a declining stock market and dwindling initial public offerings. Agios Pharmaceuticals, a Boston-based firm working on drugs designed to starve cancerous cells, has secured $33 million in venture capital. Concert Pharmaceuticals and Constellation Pharmaceuticals also each have raised more than $30 million this year.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC